WV SB329 | 2017 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on February 16 2017 - 25% progression, died in committee
Action: 2017-02-16 - To Judiciary
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on February 16 2017 - 25% progression, died in committee
Action: 2017-02-16 - To Judiciary
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [HTML]
Summary
The purpose of this bill is to address the recent prevalence of fentanyl, fentanyl derivatives and fentanyl analogs in this state, as well as the practice of misrepresenting the identity of a Schedule I controlled substance.
Title
Addressing increase of fentanyl, fentanyl derivatives and analogs in state
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2017-02-16 | Senate | To Judiciary |
| 2017-02-16 | Senate | Introduced in Senate |
| 2017-02-16 | Senate | To Judiciary then Health and Human Resources |
| 2017-02-16 | Senate | Filed for introduction |
Subjects
Code Citations
| Chapter | Article | Section | Citation Type | Statute Text |
|---|---|---|---|---|
| 60A | 1 | 101 | Amended Code | Citation Text |
| 60A | 2 | 204 | Amended Code | Citation Text |
| 60A | 4 | 414 | New Code | See Bill Text |
